Zelandia Life Science R&D Consulting ApS: Financial statements 2021
CVR: 40206051
Zelandia Life Science R&D Consulting ApS (CVR 40206051) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 830,258 and a net result of DKK 641,843 compared with DKK 236,162 the year before. That is an increase of 170.1% compared with the year before. Equity amounted to DKK 764,292. The solvency ratio was 72.8%.
- Gross Profit
- 830,258 kr.
- Profit/Loss
- 641,843 kr.
- Equity
- 764,292 kr.
- Total Assets
- 1,049,142 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 830 t. | 642 t. | 764 t. | - |
| 2020 | - | 307 t. | 236 t. | 322 t. | - |
| 2019 | - | 815 t. | 636 t. | 686 t. | - |
Find more companies like Zelandia Life Science R&D Consulting ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Zelandia Life Science R&D Consulting ApS has published its annual report for 2020. Gross profit came to DKK 307,419, and the net result was DKK 236,162.
About Zelandia Life Science R&D Consulting ApS
Zelandia Life Science R&D Consulting ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kristian Tage Hansen. The company is owned by KTHolding ApS. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580.
